Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATOS | TMO | ISRG | EW | FMS |
| Company | Atossa Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Fresenius Medical Care Ag ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 1.6900 | 580.17 | 385.55 | 87.63 | 21.88 |
| High | 1.7200 | 594.03 | 389.76 | 88.09 | 22.04 |
| Low | 1.4800 | 578.81 | 383.88 | 86.53 | 21.60 |
| Last | 1.4900 | 593.03 | 386.70 | 86.72 | 21.72 |
| Change | -0.2000 | +15.10 | +1.25 | -0.70 | +0.84 |
| % Change | -11.83% | +2.61% | +0.32% | -0.80% | +4.02% |
| Volume | 2,939,400 | 1,328,828 | 853,000 | 1,988,008 | 472,132 |
| 20-Day Average Volume | 1,579,175 | 1,520,870 | 1,409,650 | 2,873,645 | 432,140 |
| Previous Close | 1.6900 | 577.93 | 385.45 | 87.42 | 20.88 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5440 | 567.35 | 376.91 | 86.60 | 20.44 |
| 20-Day Raw Stochastic | 43.86% | 98.45% | 80.12% | 39.13% | 91.01% |
| 20-Day Relative Strength | 47.98% | 60.67% | 53.85% | 47.29% | 59.08% |
| Weighted Alpha | +76.43 | +17.24 | +29.65 | +3.61 | -2.15 |
| Today's Opinion | 40% Buy | 80% Buy | 72% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 88% Buy | 72% Buy | 72% Buy | 56% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 96% Buy | 80% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.24% since 05/03/24 | +3.61% since 05/03/24 | +1.40% since 05/03/24 | +1.72% since 05/03/24 | +3.58% since 05/03/24 |
| Low | 1.4800 on 05/10/24 | 565.34 on 05/07/24 | 380.13 on 05/08/24 | 84.81 on 05/06/24 | 19.69 on 05/07/24 |
| High | 1.8100 on 05/08/24 | 594.03 on 05/10/24 | 389.78 on 05/07/24 | 88.09 on 05/10/24 | 22.04 on 05/10/24 |
| 1-Month | |||||
| %Chg | -14.86% since 04/10/24 | +3.37% since 04/10/24 | -0.45% since 04/10/24 | -5.23% since 04/10/24 | +13.84% since 04/10/24 |
| Low | 1.2400 on 04/18/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 18.32 on 04/12/24 |
| High | 1.8400 on 04/11/24 | 594.03 on 05/10/24 | 392.80 on 04/11/24 | 92.99 on 04/11/24 | 22.04 on 05/10/24 |
| 3-Month | |||||
| %Chg | +59.24% since 02/09/24 | +7.68% since 02/09/24 | -0.39% since 02/09/24 | +2.01% since 02/09/24 | +11.16% since 02/09/24 |
| Low | 0.9500 on 02/13/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 18.32 on 04/12/24 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 22.04 on 05/10/24 |
| 6-Month | |||||
| %Chg | +134.65% since 11/10/23 | +32.25% since 11/10/23 | +39.36% since 11/10/23 | +35.06% since 11/10/23 | +26.35% since 11/10/23 |
| Low | 0.6200 on 11/13/23 | 439.11 on 11/13/23 | 281.12 on 11/13/23 | 64.07 on 11/13/23 | 17.49 on 11/13/23 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 22.04 on 05/10/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 211,764 | 220,605,120 | 136,719,120 | 52,679,288 | 12,252,948 |
| Shares Outstanding, K | 125,304 | 381,716 | 354,700 | 602,600 | 586,827 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 21,054,650,000 |
| Annual Net Income | -30,090,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 540,060,000 |
| Last Quarter Sales | 0 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 5,371,060,000 |
| Last Quarter Net Income | -7,750,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 202,510,000 |
| 60-Month Beta | 1.27 | 0.80 | 1.39 | 1.10 | 0.95 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 04/01/24 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.36 on 05/07/24 |
| Latest Earnings Date | 05/20/24 | 04/24/24 | 04/18/24 | 04/25/24 | 05/14/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | 0.415 on 05/17/23 |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | 05/17/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.53 | 81.28 | 33.37 | 14.16 |